GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity-Reference-Cited by-同舟云学术

GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity

Published:2023-12-07 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Wang Lindsey¹,Wang William¹,Kaelber David C.²,Xu Rong³⁴,Berger Nathan A.¹⁴

Affiliation:

1. Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio

2. Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences and the Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio

3. Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio

4. Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

Abstract

This cohort study compares glucagon-like peptide 1 receptor agonists (GLP-1RAs) with 7 non–GLP-1RA antidiabetics among drug-naive patients with type 2 diabetes.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2812769/jamaoncology_wang_2023_ld_230023_1701707229.78016.pdf

Reference6 articles.

1. The anti-inflammatory and immunological properties of GLP-1 receptor agonists.;Bendotti;Pharmacol Res,2022

2. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.;Currie;Diabetologia,2009

3. Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021.;Wang;JAMA Oncol,2022

4. Time trend and association of early-onset colorectal cancer with diverticular disease in the United States: 2010-2021.;Wang;Cancers (Basel),2022

5. Colorectal cancer risk factors. American Cancer Society. Accessed September 14, 2023. https://www.cancer.org/cancer/types/colon-rectal-cancer/causes-risks-prevention/risk-factors.html

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?;Diabetes, Obesity and Metabolism Now;2024-01